SNDL (SNDL) Competitors $1.67 -0.02 (-1.18%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$1.66 -0.01 (-0.60%) As of 08/7/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SNDL vs. ACB, CGC, CRON, OGI, TLRY, APGE, SPRY, SRPT, ADPT, and IMCRShould you be buying SNDL stock or one of its competitors? The main competitors of SNDL include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), Tilray Brands (TLRY), Apogee Therapeutics (APGE), ARS Pharmaceuticals (SPRY), Sarepta Therapeutics (SRPT), Adaptive Biotechnologies (ADPT), and Immunocore (IMCR). These companies are all part of the "pharmaceutical products" industry. SNDL vs. Its Competitors Aurora Cannabis Canopy Growth Cronos Group Organigram Global Tilray Brands Apogee Therapeutics ARS Pharmaceuticals Sarepta Therapeutics Adaptive Biotechnologies Immunocore SNDL (NASDAQ:SNDL) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations. Do institutionals and insiders hold more shares of SNDL or ACB? 47.6% of Aurora Cannabis shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is SNDL or ACB more profitable? Aurora Cannabis has a net margin of -5.66% compared to SNDL's net margin of -10.38%. Aurora Cannabis' return on equity of -1.48% beat SNDL's return on equity.Company Net Margins Return on Equity Return on Assets SNDL-10.38% -8.58% -7.23% Aurora Cannabis -5.66%-1.48%-1.06% Do analysts recommend SNDL or ACB? SNDL presently has a consensus target price of $4.00, suggesting a potential upside of 139.52%. Given SNDL's higher possible upside, equities analysts plainly believe SNDL is more favorable than Aurora Cannabis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SNDL 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.67 Does the media refer more to SNDL or ACB? In the previous week, SNDL had 8 more articles in the media than Aurora Cannabis. MarketBeat recorded 12 mentions for SNDL and 4 mentions for Aurora Cannabis. SNDL's average media sentiment score of 0.88 beat Aurora Cannabis' score of -0.38 indicating that SNDL is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SNDL 4 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Aurora Cannabis 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility and risk, SNDL or ACB? SNDL has a beta of 3.57, suggesting that its share price is 257% more volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.84, suggesting that its share price is 84% more volatile than the S&P 500. Which has preferable valuation and earnings, SNDL or ACB? Aurora Cannabis has lower revenue, but higher earnings than SNDL. SNDL is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSNDL$671.81M0.65-$69.18M-$0.27-6.19Aurora Cannabis$246.72M0.96$1.63M$0.1138.27 SummaryAurora Cannabis beats SNDL on 11 of the 17 factors compared between the two stocks. Get SNDL News Delivered to You Automatically Sign up to receive the latest news and ratings for SNDL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SNDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNDL vs. The Competition Export to ExcelMetricSNDLMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$444.09M$10.34B$5.48B$9.57BDividend YieldN/A2.03%4.00%4.18%P/E Ratio-6.1819.2529.8825.14Price / Sales0.6523.11440.19102.95Price / CashN/A21.8135.9458.58Price / Book0.562.848.105.59Net Income-$69.18M$211.77M$3.26B$265.48M7 Day Performance1.21%1.54%0.65%1.22%1 Month Performance21.01%2.31%2.44%0.39%1 Year Performance-20.85%-11.48%27.59%23.47% SNDL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNDLSNDL2.8001 of 5 stars$1.67-1.2%$4.00+139.5%-17.3%$444.09M$671.81M-6.182,516Earnings ReportAnalyst RevisionACBAurora Cannabis0.5377 of 5 stars$4.62+3.1%N/A-32.6%$259.86M$343.29M42.001,130Earnings ReportCGCCanopy Growth0.5611 of 5 stars$1.10+4.8%N/A-83.6%$225.66M$269.00M-0.273,150CRONCronos Group2.2471 of 5 stars$2.02+3.6%N/A+2.3%$779.08M$124.59M15.54450Earnings ReportOGIOrganigram Global1.2517 of 5 stars$1.38+3.8%N/A-5.4%$184.96M$194.09M13.80860Upcoming EarningsGap UpTLRYTilray Brands3.0927 of 5 stars$0.61+6.9%$1.92+215.3%-62.8%$611.75M$210.48M-0.262,650Options VolumeAPGEApogee Therapeutics2.6585 of 5 stars$37.24-1.4%$99.00+165.8%-11.9%$1.71BN/A-10.3491Positive NewsUpcoming EarningsSPRYARS Pharmaceuticals3.4002 of 5 stars$17.38+1.2%$31.00+78.4%+84.5%$1.71B$89.15M-108.6290Positive NewsUpcoming EarningsSRPTSarepta Therapeutics4.609 of 5 stars$17.10+7.5%$49.12+187.3%-87.2%$1.68B$1.90B-6.361,372Trending NewsEarnings ReportAnalyst ForecastHigh Trading VolumeADPTAdaptive Biotechnologies2.9894 of 5 stars$10.91+5.6%$11.33+3.9%+199.3%$1.66B$189.53M-11.36790Trending NewsEarnings ReportAnalyst ForecastGap DownIMCRImmunocore1.7414 of 5 stars$32.53-1.4%$58.89+81.0%-13.5%$1.63B$333.58M-75.65320News CoveragePositive NewsEarnings Report Related Companies and Tools Related Companies Aurora Cannabis Alternatives Canopy Growth Alternatives Cronos Group Alternatives Organigram Global Alternatives Tilray Brands Alternatives Apogee Therapeutics Alternatives ARS Pharmaceuticals Alternatives Sarepta Therapeutics Alternatives Adaptive Biotechnologies Alternatives Immunocore Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SNDL) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SNDL Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SNDL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
